new oral antiviral for chronic hepatitis B called Baraclude (entecavir)
October 2006
Health Canada has approved a new oral antiviral for chronic hepatitis B called Baraclude (entecavir).
It will be used as an alternative to Intron A (interferon alfa-2b)...Heptovir (lamivudine)...or Hepsera (adefovir).
Intron A is effective for suppressing the hepatitis B virus and requires a shorter treatment duration than the oral antivirals.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive